PL426093A1 - Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie - Google Patents

Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie

Info

Publication number
PL426093A1
PL426093A1 PL426093A PL42609318A PL426093A1 PL 426093 A1 PL426093 A1 PL 426093A1 PL 426093 A PL426093 A PL 426093A PL 42609318 A PL42609318 A PL 42609318A PL 426093 A1 PL426093 A1 PL 426093A1
Authority
PL
Poland
Prior art keywords
bst
polymerase
dna
phusion polymerase
neqssb
Prior art date
Application number
PL426093A
Other languages
English (en)
Inventor
Marta ŚPIBIDA
Kasjan Szemianko
Marcin Olszewski
Dawid Midzworski
Original Assignee
Instytut Biotechnologii I Medycyny Molekularnej
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biotechnologii I Medycyny Molekularnej filed Critical Instytut Biotechnologii I Medycyny Molekularnej
Priority to PL426093A priority Critical patent/PL426093A1/pl
Priority to JP2020571711A priority patent/JP2021528968A/ja
Priority to EP19743078.8A priority patent/EP3814368A1/en
Priority to US17/253,445 priority patent/US20210254034A1/en
Priority to CN201980017798.1A priority patent/CN111819188A/zh
Priority to PCT/PL2019/000046 priority patent/WO2020005084A1/en
Publication of PL426093A1 publication Critical patent/PL426093A1/pl
Priority to IL279262A priority patent/IL279262A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/24—Extraction; Separation; Purification by electrochemical means
    • C07K1/26—Electrophoresis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/10—Nucleotidyl transfering
    • C12Q2521/101—DNA polymerase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Electrochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Przedmiotem zgłoszenia jest fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst połączona z białkiem NeqSSB na N-końcu polimerazy za pomocą 6-aminokwasowego linkera o sekwencji aminokwasowej Gly-Ser-Gly-Gly-Val-Asp, gdzie wspomniana polimeraza występuje w trzech różnych odmianach oraz sposób jej otrzymywania. Ponadto przedmiotem zgłoszenia jest cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst Full Length, Large Fragment, Short Fragment oraz zastosowanie in vitro fuzyjnej polimerazy kwasu jednołańcuchowego DNA Bst.
PL426093A 2018-06-27 2018-06-27 Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie PL426093A1 (pl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
PL426093A PL426093A1 (pl) 2018-06-27 2018-06-27 Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie
JP2020571711A JP2021528968A (ja) 2018-06-27 2019-06-26 融合一本鎖ＤＮＡポリメラーゼＢｓｔ、融合ＤＮＡポリメラーゼＮｅｑＳＳＢ−Ｂｓｔをコードする核酸分子、その調製方法およびその利用
EP19743078.8A EP3814368A1 (en) 2018-06-27 2019-06-26 Fusion single-stranded dna polymerase bst, nucleic acid molecule encoding fusion dna polymerase neqssb-bst, method of preparation and utilisation thereof
US17/253,445 US20210254034A1 (en) 2018-06-27 2019-06-26 Fusion single-stranded dna polymerase bst, nucleic acid molecule encoding fusion dna polymerase neqssb-bst, method of preparation and utilisation thereof
CN201980017798.1A CN111819188A (zh) 2018-06-27 2019-06-26 融合单链DNA聚合酶Bst、编码融合DNA聚合酶NeqSSB-Bst的核酸分子、其制备方法和用途
PCT/PL2019/000046 WO2020005084A1 (en) 2018-06-27 2019-06-26 Fusion single-stranded dna polymerase bst, nucleic acid molecule encoding fusion dna polymerase neqssb-bst, method of preparation and utilisation thereof
IL279262A IL279262A (en) 2018-06-27 2020-12-07 Fusion of single-stranded DNA polymerase BST, a molecule of nucleic acid that codes for the fusion of DNA polymerase NEQSSB-BST, a method for their preparation and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL426093A PL426093A1 (pl) 2018-06-27 2018-06-27 Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie

Publications (1)

Publication Number Publication Date
PL426093A1 true PL426093A1 (pl) 2020-01-02

Family

ID=67402999

Family Applications (1)

Application Number Title Priority Date Filing Date
PL426093A PL426093A1 (pl) 2018-06-27 2018-06-27 Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie

Country Status (7)

Country Link
US (1) US20210254034A1 (pl)
EP (1) EP3814368A1 (pl)
JP (1) JP2021528968A (pl)
CN (1) CN111819188A (pl)
IL (1) IL279262A (pl)
PL (1) PL426093A1 (pl)
WO (1) WO2020005084A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009005289B4 (de) 2009-01-20 2023-06-22 Merck Patent Gmbh Materialien für organische Elektrolumineszenzvorrichtungen, Verfahren zu deren Herstellung und elektronische Vorrichtungen, enthaltend diese
PL241065B1 (pl) * 2020-06-26 2022-08-01 Geneme Spolka Z Ograniczona Odpowiedzialnoscia Zastosowanie fuzyjnej polimerazy DNA Bst-Nec do izotermalnego powielania specyficznych sekwencji wirusa SARS CoV-2
PL241698B1 (pl) * 2021-01-27 2022-11-21 Inst Biotechnologii I Medycyny Molekularnej Polimeraza Pwo-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
CN112899255B (zh) * 2021-03-06 2022-02-25 苏州瀚源新酶生物科技有限公司 Dna聚合酶及其应用、重组载体及其制备方法和应用、重组工程菌及其应用
PL243940B1 (pl) * 2021-05-19 2023-11-06 Inst Biotechnologii I Medycyny Molekularnej Polimeraza Taq-NeqSSB, sposób jej otrzymywania, plazmid rekombinantowy, startery oraz zastosowanie polimerazy
CN115094047B (zh) * 2022-06-24 2023-06-20 华南理工大学 一种直扩型Bst DNA聚合酶及其制备方法与应用
CN115058404A (zh) * 2022-07-25 2022-09-16 通用生物(南京)有限公司 一种新型的dna合成连接酶
CN115701839A (zh) * 2023-01-05 2023-02-14 深圳无微华斯生物科技有限公司 一种恒温扩增试剂盒及常温保存方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007050125A2 (en) * 2005-05-27 2007-05-03 William Marsh Rice University High processivity polymerases
US20070059713A1 (en) * 2005-09-09 2007-03-15 Lee Jun E SSB-DNA polymerase fusion proteins
EP2393933A4 (en) * 2009-02-04 2013-05-01 Lucigen Corp RNA AND DNA COPIERING ENZYMES
US20130260422A1 (en) * 2011-09-01 2013-10-03 New England Biolabs, Inc. Compositions and Methods Relating to Variant DNA Polymerases and Synthetic DNA Polymerases
US9963687B2 (en) * 2014-08-27 2018-05-08 New England Biolabs, Inc. Fusion polymerase and method for using the same

Also Published As

Publication number Publication date
IL279262A (en) 2021-01-31
WO2020005084A1 (en) 2020-01-02
EP3814368A1 (en) 2021-05-05
CN111819188A (zh) 2020-10-23
JP2021528968A (ja) 2021-10-28
US20210254034A1 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
PL426093A1 (pl) Fuzyjna polimeraza kwasu jednołańcuchowego DNA Bst, cząsteczka kwasu nukleinowego kodująca fuzyjną polimerazę DNA NeqSSB-Bst, sposób jej otrzymywania oraz zastosowanie
PE20191463A1 (es) Anticuerpos biespecificos de union especifica pd1 y lag3
PE20181092A1 (es) Anticuerpos anti-pd1 y metodos de uso
AR095432A1 (es) Proteínas de unión a antígeno
AU2018256487A1 (en) Antibodies that bind to TL1A and their uses
DOP2019000011A (es) Proteínas de unión de tipo anticuerpo biespecíficas que se unen específicamente a cd3 y cd123
PE20180480A1 (es) Anticuerpos de factor xi y metodos de uso
PE20180604A1 (es) Anticuerpos pd-l1 (que se unen al ligando 1 de muerte celular programada 1 humana)
UA117575C2 (uk) Антитіло, яке специфічно зв'язується з il-17a та його застосування
EA201400568A1 (ru) Альбуминсвязывающие антитела и их связывающие фрагменты
AR080793A1 (es) Anticuerpos biespecificos
ES2687282T3 (es) Anticuerpos humanizados ANTI-CD134 (OX40) y sus usos
ES2670621T3 (es) Anticuerpos que se unen a OX40 y sus usos
PE20150023A1 (es) Proteinas de union a antigeno st2
CO6280541A2 (es) Anticuerpos monoclonales o fragmentos del mismo que se unen al recptor humano ox40
UA106607C2 (uk) Білки специфічного зв'язування і їх застосування
BR112015022978A2 (pt) agente de ligação biespecífico, seu método de produção composição farmacêutica, proteína de fusão, uso, sequência de ácido nucleico, vetor, célula hospedeira, método de matar células tumorais e de inibir o crescimento tumoral
PE20181054A1 (es) Anticuerpos anti-cd19 humano humanizados y metodos de utilizacion
AR077088A1 (es) Proteinas biespecificas de union a antigeno
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
EA201490745A1 (ru) Полипептиды антител, которые вызывают антагонизм cd40l
AR065433A1 (es) Anticuerpos anti-cxcl13
EA201792466A1 (ru) АНТИТЕЛА ПРОТИВ FcRn
MX2017004117A (es) Moleculas de enlace, especialmente anticuerpos, enlazadas a l1cam(cd171).
EA201790236A1 (ru) Антитела против vasa и способы их получения и использования